Press Releases
- Final results from Active Biotech's 10TASQ10 Phase 3 study of tasquinimod presented at the ECC conference September 28, 2015 08:39 (CEST)
- Final results from Active Biotech's 10TASQ10 Phase 3 study of tasquinimod presented at the ECC conference September 28, 2015 08:30 (CEST)
- Active Biotech AB Interim report January - June 2015 August 7, 2015 08:38 (CEST)
- Active Biotech AB Interim report January - June 2015 August 7, 2015 08:30 (CEST)
- Teva and Active Biotech Announce Completion of Patient Enrollment in Laquinimod Phase III CONCERTO Trial June 25, 2015 14:27 (CEST)
- Teva and Active Biotech Announce Completion of Patient Enrollment in Laquinimod Phase III CONCERTO Trial June 25, 2015 14:00 (CEST)
- Annual General Meeting of Active Biotech AB June 12, 2015 08:33 (CEST)
- Annual General Meeting of Active Biotech AB June 12, 2015 08:30 (CEST)
- Active Biotech focuses the operations on the laquinimod project and adjusts the organization June 1, 2015 10:03 (CEST)
- Active Biotech focuses the operations on the laquinimod project and adjusts the organization June 1, 2015 10:00 (CEST)